Engineered lipid nanoparticles reprogram immune metabolism for better mRNA vaccines

Penn researchers have engineered a new lipid nanoparticle, C12-2aN, that rewires immune cell metabolism to boost mRNA vaccine potency while cutting typical side‑effects, showing promise in human cell and mouse tests.